Inventor

Mutsuo Taiji

Inventor

Takatsuki, JP

Overview

6→

Patents

2002–2005

Patent span

Human necessities

Primary field (CPC A)

Patents· 6 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes50%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%

C07CAcyclic or carbocyclic compounds8%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium8%

C07KPeptides8%

PatentTitleYear

6,887,477'Method of treating ischemic disease by intramuscular administration of Hepatocyte growth factor'2005 6,800,607'Modified BDNF'2004 6,689,745'Agent for ameliorating pancreatic function disorder'2004 6,472,366'Hepatocyte growth factor for treatment of diabetes'2002 6,399,658'Composition containing ascorbic acid'2002 6,391,312'Remedies for diabetes'2002

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2002–2004Patents assigned to SUMITOMO PHARMA (4)· patent assignee history

2002–2004Based in Takatsuki, JP· patent location history

2004Patents assigned to LTT BIO PHARMA CO LTD (1)· patent assignee history

2005Based in Osaka-shi, JP· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
SUMITOMO PHARMA	4	2002–2004
LTT BIO PHARMA CO LTD	1	2004

Locations

Location	Patents	Span
Takatsuki, JP	5	2002–2004
Osaka-shi, JP	1	2005